HK2 and ovarian carcinoma: As shown in this study, HK2 overexpression could activate Wnt/β-catenin pathway by up-regulating β-catenin expression, further promoting cell proliferation and tumor formation by inducing c-myc and Cyclin D1 expression in ovarian cancer cells.